Dr Kate Shemilt

Pharmacy and Biomolecular Sciences

Kate is a registered pharmacist of the GPhC, with a range of experience working within clinical practice and academia. After successfully completing her pre-registration training at The Royal Shrewsbury Hospital, Kate continued working as a rotational hospital pharmacist. In 2005 she gained her Postgraduate Diploma in Clinical Pharmacy at Keele University before moving to the Republic of Ireland where she specialised in Oncology at St James's hospital, Dublin.

Kate completed her PhD in collaboration with the Countess of Chester NHS Foundation Trust in 2015. For her PhD, she investigated the impact of electronic prescribing systems on healthcare professionals working practices. Kate is a member of the Clinical Pharmacy and Therapeutics research group. She supervises undergraduate and postgraduate taught (Masters) students in the fields of clinical pharmacy and pharmacy practice. Her research interests focus on patient safety, specifically relating to medication errors, medicines optimisation and the use of electronic prescribing systems.

Kate has been a member of teaching staff within the School of Pharmacy since 2014. As a Senior Lecturer she is actively involved in teaching on the Master of Pharmacy (MPharm) programme and postgraduate pharmacy courses. Kate holds a PgCert HE (distinction) and is a fellow of the Higher Education Academy. Kate's current administrative roles include Competency Lead for Dispensing on the MPharm degree and Programme Lead for the PG Oncology Pharmacy Practice CPD courses. Kate is a member of the British Oncology Pharmacy Association (BOPA).


Liverpool John Moores University, United Kingdom, MPharm
Liverpool John Moores University, United Kingdom, PhD

Academic appointments

Senior Lecturer in Clinical Pharmacy, School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, 2014 - present

Postgraduate training

Clinical Pharmacy: Postgraduate Diploma, United Kingdom, Keele University, ? - present
Oncology Pharmacy Practice: Certificate of Professional Development, United Kingdom, Liverpool John Moores University, ? - present
Learning and Teaching in Higher Education: Postgraduate Certificate, United Kingdom, Liverpool John Moores University, ? - present

Journal article

Court OR, Shemilt K. 2021. Lonsurf (trifluridine/tipiracil): assessing the impact of dose related toxicities and progression free survival in (refractory) metastatic colorectal cancer (May, 10.1177/10781552211017973, 2021) JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 28 :259-259 DOI Author Url

Court OR, Shemilt K. 2021. Lonsurf (trifluridine/tipiracil): Assessing the impact of dose related toxicities and progression free survival in (refractory) metastatic colorectal cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, :10781552211017973 DOI Author Url

Shemilt K, Morecroft CW, Ford JL, Mackridge AJ, Green C. 2019. Impact of including clinical indications on inpatient prescriptions Clinical Pharmacist, 11 DOI

Shemilt K, Morecroft CW, Ford J, Mackridge AJ, Green C. 2016. Inpatient prescribing systems used in NHS Acute 65 66 Trusts across England: a managerial perspective European Journal of Hospital Pharmacy: Science and Practice, DOI Author Url Publisher Url Public Url

Shemilt K, Airley R, Clareburt C. 2011. An evaluation of the impact of NICE guidelines regarding COX-2 selective inhibitors on GP prescribing International Journal of Pharmacy Practice, 10 :R78-R78 DOI


Arnold M, Lavery JV, Murphy M, Shemilt K. 2021. Innovations in Remote Learning; Electronic Prescribing and Medications Administration (EPMA) Systems in Nurse Education The Royal College of Nursing Education Conference Public Url




Fellow, Higher Education Academy. 2017

Teaching qualification:

Postgraduate Certificate of Teaching and Learning in Higher Education. 2017

Membership of professional bodies:

Registered Pharmacist, General Pharmaceutical Council. 2003

Member, British Oncology Pharmacy Association (BOPA).

Other Professional Activity:

Peer reviewer Pharmacy Research UK (PRUK).